 REHOVOT, Israel, Feb. 03, 2021 GLOBE NEWSWIRE -- Kamada Ltd. NASDAQ TASE: KMDA, plasma-derived biopharmaceutical company, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2020, prior to the open of the U.S. financial markets on Wednesday, February 10, 2021. 